Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Non-Adherence to Asthma a Growing Problem

An analysis published in the Journal of Clinical Pharmacy and Therapeutics of asthma medication adherence showed poor coverage across a six-month period.

New Recs for IPF Rx Therapy

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association have been published.

Cloud9 Anti-Snoring System Approved

The FDA has cleared its Cloud9 Anti-Snoring System to reduce or eliminate asymptomatic ("simple") snoring in adults.

When Should LABA Therapy Be Stopped?

An article highlights studies on cessation of LABA compared to continued use of LABA/ICS for adults with well-controlled asthma to determine whether stopping LABA treatment has an impact on asthma control, exacerbations, and other serious adverse events.

Soy Supplements for Uncontrolled Asthma

A new study has found that supplementation with soy isoflavone did not improve lung function or critical outcomes in patients with poor asthma control, despite previous research suggesting that it may be an effective treatment.

Regular Aspirin May Slow Emphysema Progression

Regular aspirin use is associated with a slower progression of early emphysema on computed tomography (CT) scans over the course of 10 years.

Breo Ellipta Inhaler Gains Expanded Indication

GlaxoSmithKline and Theravance announced that the Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged ≥18 years.

COPD and Sudden Cardiac Death Risk

Chronic obstructive pulmonary disease (COPD) is already the third leading cause of death in the world, and the condition might also raise a patient's odds for sudden cardiac death.


New Bluetooth-Enabled Thermometer Launched With App

Vicks announced the launch of its new Vicks SmartTemp wireless smartphone thermometer, the the first bluetooth enabled thermometer that comes with a companion app.

Six-Minute Walk Distance Tied to Lung Transplant Survival

Increase in walk distance up to 1,400 feet confers incremental survival advantage

Two Decision Instruments ID Major Injuries in Blunt Trauma

Decision instruments have high sensitivity for identifying clinically significant thoracic injuries

Kalydeco sNDA Granted Priority Review for Expanded Indication

The Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) of Kalydeco (ivacaftor; Vertex) for the use in patients with cystic fibrosis (CF) ages 2 and older who have one of 23 residual function mutations.

Featured courses from mycme

Comprehensive Review of Family MedicineExternal web site

This comprehensive review covers the full spectrum of topics applicable to Family Medicine through lectures ...

CME 57.00 Credits

Reduced-Nicotine Cigarettes: Safer Than Conventional Products?External web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

ACP Guideline Calls for Smarter Testing in PE EvaluationExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters